Over five years, non-GLP-1 spending increases by $6,800, or 30 percent of the amount spent on GLP-1s
Both therapies improve metabolic markers like A1C, cholesterol, and inflammation, but require medical supervision
However, retatrutide is still in Phase 3 trials and not yet FDA-approved, so direct real-world comparisons are not yet possible
On pricing, Found's cash compounded-semaglutide program is $289/month, billed every four weeks 13 charges a year on the monthly plan with medication included and no separate membership fee
For GLP-1 claims, the applicable statute of limitations depends on the state where you live or where your medication was prescribed, and its typically two years from the date of your medical diagnosis
Selected tests may be useful when food intake becomes very limited or symptoms suggest anemia or deficiency